| __timestamp | Regeneron Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 242549000 |
| Thursday, January 1, 2015 | 1620577000 | 245098000 |
| Friday, January 1, 2016 | 2052295000 | 147600000 |
| Sunday, January 1, 2017 | 2075142000 | 264600000 |
| Monday, January 1, 2018 | 2186100000 | 357900000 |
| Tuesday, January 1, 2019 | 3036600000 | 1182600000 |
| Wednesday, January 1, 2020 | 2735000000 | 357700000 |
| Friday, January 1, 2021 | 2908100000 | 540100000 |
| Saturday, January 1, 2022 | 3592500000 | 322900000 |
| Sunday, January 1, 2023 | 4439000000 | 408000000 |
| Monday, January 1, 2024 | 5132000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Regeneron Pharmaceuticals, Inc. and United Therapeutics Corporation have been at the forefront of this race. From 2014 to 2023, Regeneron consistently outpaced United Therapeutics in research and development (R&D) spending, investing nearly 6 times more on average. In 2023, Regeneron's R&D expenses soared to a staggering $4.4 billion, marking a 250% increase from 2014. Meanwhile, United Therapeutics' investment peaked at $1.18 billion in 2019, a significant leap from its 2014 expenditure. This trend underscores Regeneron's commitment to innovation, positioning it as a leader in the biotech industry. As these companies continue to push the boundaries of medical science, their R&D investments will be crucial in shaping the future of healthcare.
Comparing Innovation Spending: Gilead Sciences, Inc. and Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Neurocrine Biosciences, Inc.: Strategic Focus on R&D Spending
Regeneron Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Regeneron Pharmaceuticals, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: United Therapeutics Corporation vs Xenon Pharmaceuticals Inc.
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
United Therapeutics Corporation vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.